nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—exocrine gland—cervical cancer	0.103	0.147	CbGeAlD
Auranofin—PRDX5—epithelium—cervical cancer	0.0448	0.0641	CbGeAlD
Auranofin—PRDX5—uterine cervix—cervical cancer	0.0444	0.0635	CbGeAlD
Auranofin—PRDX5—decidua—cervical cancer	0.0423	0.0605	CbGeAlD
Auranofin—PRDX5—renal system—cervical cancer	0.0415	0.0594	CbGeAlD
Auranofin—PRDX5—endometrium—cervical cancer	0.0401	0.0575	CbGeAlD
Auranofin—PRDX5—mammalian vulva—cervical cancer	0.0388	0.0556	CbGeAlD
Auranofin—PRDX5—uterus—cervical cancer	0.037	0.053	CbGeAlD
Auranofin—PRDX5—female reproductive system—cervical cancer	0.0333	0.0476	CbGeAlD
Auranofin—PRDX5—female gonad—cervical cancer	0.0303	0.0433	CbGeAlD
Auranofin—PRDX5—vagina—cervical cancer	0.0301	0.0431	CbGeAlD
Auranofin—IKBKB—uterine cervix—cervical cancer	0.0263	0.0376	CbGeAlD
Auranofin—IKBKB—decidua—cervical cancer	0.025	0.0359	CbGeAlD
Auranofin—IKBKB—endometrium—cervical cancer	0.0238	0.034	CbGeAlD
Auranofin—IKBKB—mammalian vulva—cervical cancer	0.023	0.0329	CbGeAlD
Auranofin—IKBKB—uterus—cervical cancer	0.0219	0.0314	CbGeAlD
Auranofin—IKBKB—female reproductive system—cervical cancer	0.0197	0.0282	CbGeAlD
Auranofin—PRDX5—Cellular responses to stress—CA9—cervical cancer	0.0195	0.0646	CbGpPWpGaD
Auranofin—PRDX5—lymph node—cervical cancer	0.0195	0.0279	CbGeAlD
Auranofin—PRDX5—Selenium Micronutrient Network—MTHFR—cervical cancer	0.019	0.0631	CbGpPWpGaD
Auranofin—IKBKB—female gonad—cervical cancer	0.0179	0.0257	CbGeAlD
Auranofin—IKBKB—vagina—cervical cancer	0.0178	0.0255	CbGeAlD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—PIAS3—cervical cancer	0.0169	0.0559	CbGpPWpGaD
Auranofin—IKBKB—lymph node—cervical cancer	0.0115	0.0165	CbGeAlD
Auranofin—IKBKB—mTOR signaling pathway—YY1—cervical cancer	0.0102	0.0339	CbGpPWpGaD
Auranofin—IKBKB—NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10—CASP8—cervical cancer	0.00935	0.031	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—HLA-DPB1—cervical cancer	0.00686	0.0228	CbGpPWpGaD
Auranofin—ALB—lymph node—cervical cancer	0.00673	0.00963	CbGeAlD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—AKAP13—cervical cancer	0.00588	0.0195	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—HLA-DQB1—cervical cancer	0.00536	0.0178	CbGpPWpGaD
Auranofin—IKBKB—TRAIL signaling pathway—CASP8—cervical cancer	0.0052	0.0172	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—HLA-DPB1—cervical cancer	0.00513	0.017	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—MTOR—cervical cancer	0.00508	0.0169	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—WNT5A—cervical cancer	0.00498	0.0165	CbGpPWpGaD
Auranofin—IKBKB—Type II diabetes mellitus—MTOR—cervical cancer	0.00474	0.0157	CbGpPWpGaD
Auranofin—IKBKB—NOD1/2 Signaling Pathway—CASP8—cervical cancer	0.00438	0.0145	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—cervical cancer	0.00407	0.0135	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—HLA-DQB1—cervical cancer	0.004	0.0133	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—CASP8—cervical cancer	0.00397	0.0132	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—STAT3—cervical cancer	0.00393	0.013	CbGpPWpGaD
Auranofin—IKBKB—NOD pathway—CASP8—cervical cancer	0.0035	0.0116	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—CASP8—cervical cancer	0.00343	0.0114	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —CASP8—cervical cancer	0.00319	0.0106	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.0031	0.0103	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—CASP3—cervical cancer	0.003	0.00997	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—TP53—cervical cancer	0.003	0.00995	CbGpPWpGaD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP8—cervical cancer	0.00298	0.0099	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—CD4—cervical cancer	0.00287	0.00953	CbGpPWpGaD
Auranofin—IKBKB—IL17 signaling pathway—STAT3—cervical cancer	0.00278	0.00923	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00271	0.00898	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—CD8A—cervical cancer	0.00267	0.00885	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—CASP3—cervical cancer	0.0026	0.00861	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—cervical cancer	0.0025	0.0083	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—CTNNB1—cervical cancer	0.0025	0.0083	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—STAT3—cervical cancer	0.00241	0.00801	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP8—cervical cancer	0.00239	0.00793	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—MTOR—cervical cancer	0.00228	0.00755	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—MTOR—cervical cancer	0.00228	0.00755	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—CTNNB1—cervical cancer	0.00221	0.00734	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKAP13—cervical cancer	0.00217	0.00718	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—CD4—cervical cancer	0.00215	0.00712	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—STAT3—cervical cancer	0.0021	0.00697	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CASP8—cervical cancer	0.00205	0.0068	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.00198	0.00658	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—cervical cancer	0.00198	0.00658	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP8—cervical cancer	0.00197	0.00654	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—MTOR—cervical cancer	0.00197	0.00652	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—cervical cancer	0.00196	0.00651	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP8—cervical cancer	0.00185	0.00613	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP8—cervical cancer	0.00183	0.00608	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP3—cervical cancer	0.00181	0.006	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—STAT3—cervical cancer	0.00178	0.00592	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—MTOR—cervical cancer	0.00178	0.00589	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—CASP3—cervical cancer	0.00175	0.00579	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—CTNNB1—cervical cancer	0.00174	0.00578	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—CASP8—cervical cancer	0.00173	0.00573	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.00172	0.00571	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CASP8—cervical cancer	0.00169	0.0056	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—MTOR—cervical cancer	0.00162	0.00538	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—MTHFR—cervical cancer	0.00161	0.00536	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPIND1—cervical cancer	0.0016	0.0053	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GP6—cervical cancer	0.0016	0.0053	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—CASP8—cervical cancer	0.00155	0.00516	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—CD4—cervical cancer	0.00153	0.00508	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—CASP3—cervical cancer	0.00152	0.00504	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—STAT3—cervical cancer	0.00152	0.00504	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.0015	0.00498	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP3—cervical cancer	0.00149	0.00495	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DPB1—cervical cancer	0.00148	0.00489	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—CASP8—cervical cancer	0.00146	0.00485	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—cervical cancer	0.00144	0.00477	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP3—cervical cancer	0.0014	0.00464	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GP5—cervical cancer	0.0014	0.00463	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP3—cervical cancer	0.00139	0.0046	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—cervical cancer	0.00138	0.00458	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—STAT3—cervical cancer	0.00137	0.00455	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.00136	0.00453	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—UBE3A—cervical cancer	0.00133	0.00441	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cervical cancer	0.00133	0.00441	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CASP8—cervical cancer	0.00132	0.00437	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—CASP8—cervical cancer	0.0013	0.00432	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00128	0.00425	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—cervical cancer	0.00127	0.00421	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—STAT3—cervical cancer	0.00125	0.00416	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—FGFR3—cervical cancer	0.00118	0.0039	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.00115	0.00382	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.00115	0.0038	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP8—cervical cancer	0.00113	0.00376	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—cervical cancer	0.00112	0.00371	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MTOR—cervical cancer	0.00105	0.0035	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—STAT3—cervical cancer	0.00102	0.0034	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CASP3—cervical cancer	0.000969	0.00321	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MTOR—cervical cancer	0.000968	0.00321	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—cervical cancer	0.000956	0.00317	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	0.000936	0.0031	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CTNNB1—cervical cancer	0.000934	0.0031	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—cervical cancer	0.000897	0.00298	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	0.000893	0.00296	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FGFR3—cervical cancer	0.000865	0.00287	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP3—cervical cancer	0.000857	0.00284	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—MTOR—cervical cancer	0.000827	0.00274	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—STAT3—cervical cancer	0.000814	0.0027	CbGpPWpGaD
Auranofin—IKBKB—Immune System—UBE3A—cervical cancer	0.000807	0.00268	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DPB1—cervical cancer	0.000794	0.00264	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TAAR6—cervical cancer	0.000679	0.00225	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—cervical cancer	0.000657	0.00218	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—cervical cancer	0.000654	0.00217	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.000627	0.00208	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DQB1—cervical cancer	0.00062	0.00206	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—cervical cancer	0.000613	0.00203	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MTOR—cervical cancer	0.000608	0.00202	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—cervical cancer	0.000581	0.00193	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—cervical cancer	0.000579	0.00192	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—cervical cancer	0.00056	0.00186	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—cervical cancer	0.000549	0.00182	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—WNT2—cervical cancer	0.00053	0.00176	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGFR3—cervical cancer	0.000493	0.00164	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DPB1—cervical cancer	0.000482	0.0016	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000478	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGFR3—cervical cancer	0.000474	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—cervical cancer	0.00047	0.00156	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKAP13—cervical cancer	0.000465	0.00154	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—cervical cancer	0.000427	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP8—cervical cancer	0.000422	0.0014	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—WNT5A—cervical cancer	0.000401	0.00133	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DQB1—cervical cancer	0.000376	0.00125	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—cervical cancer	0.000351	0.00117	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MTOR—cervical cancer	0.000347	0.00115	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—cervical cancer	0.000346	0.00115	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—cervical cancer	0.000333	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—cervical cancer	0.000333	0.0011	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA9—cervical cancer	0.000316	0.00105	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—cervical cancer	0.000308	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR3—cervical cancer	0.000287	0.000953	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH2—cervical cancer	0.000282	0.000935	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—cervical cancer	0.000246	0.000815	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—cervical cancer	0.000244	0.000809	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—cervical cancer	0.000234	0.000777	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HES1—cervical cancer	0.000231	0.000766	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—cervical cancer	0.000202	0.000672	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—cervical cancer	0.000202	0.000671	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—cervical cancer	0.000202	0.000669	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR3—cervical cancer	0.000186	0.000616	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—cervical cancer	0.000179	0.000595	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH1—cervical cancer	0.000174	0.000579	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—cervical cancer	0.000156	0.000518	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—cervical cancer	0.000142	0.000471	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—cervical cancer	0.000131	0.000434	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—cervical cancer	0.000128	0.000426	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000399	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—cervical cancer	0.00012	0.000399	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000384	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—cervical cancer	0.000101	0.000335	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—cervical cancer	9.18e-05	0.000305	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—cervical cancer	7.71e-05	0.000256	CbGpPWpGaD
